Breast Cancer

Learn about the FDA approval of Veppanu, the first PROTAC for ER+/HER2- metastatic breast cancer with ESR1 mutations.

A cancer survivor reflects on the profound power of physician communication, highlighting how words can either validate hope or deepen patient pain.

A breast cancer survivor shares how faith and community prayer provided unexplainable peace and a new mission to offer hope to others in need.

Following the FDA approval of Veppanu for ESR1-mutant breast cancer, Dr. Komal Jhaveri explains this new therapy that destroys cancer receptors.

Phase 3 VIKTORIA-1 trial shows gedatolisib triplet therapy significantly extends progression-free survival for HR+/HER2- advanced breast cancer.

Learn about rare phyllodes tumors, from benign to malignant grades, including surgical options, recovery and key questions for your oncology team.

Following FDA approval, Veppanu (vepdegestrant) provides a new oral treatment option for patients with ESR1-mutated, ER+/HER2- metastatic breast cancer.

Summer, with its promise of warmth and freedom, can present unexpected challenges for breast cancer survivors navigating life after a mastectomy.

New AHN research shows high-intensity resistance training is safe and essential for breast cancer survivors to gain strength and functional mobility.

Phase 3 trial shows Datroway significantly extended overall and progression-free survival in patients with previously untreated, advanced TNBC ineligible for immunotherapy.

Dr. Nguyen shares how breast cancer patients in rural areas can overcome travel barriers and confidently discuss clinical trials with their doctors.

Learn why timing and muscle health are vital when using GLP-1 therapy for weight management during and after breast cancer treatment.

Learn about Paget disease of the breast, a rare cancer affecting the nipple. Explore symptoms, diagnostic steps and common treatment options.

Breast cancer survivor Anna Wassman-Cox discusses the Onco-Ballet Foundation and how dance provides healing and community for Stage IV patients.

Learn about breast angiosarcoma, a rare blood vessel cancer. Discover the signs of primary and secondary cases to help guide your oncology discussion.

Moving into a new home often means sorting through years of belongings. Sometimes, hidden in a box, we uncover pieces of the past that force us to confront what we’ve endured.

The OPTIMAL trial finds oral DHP107 is as effective as IV paclitaxel for patients with advanced breast cancer while reducing side effects like neuropathy.

Before my daughter was diagnosed with breast cancer, the “M” word was not a part of my vocabulary.

After an aggressive breast cancer diagnosis, psychologist Loraine Alderman retires to bridge gaps in patient literature through powerful advocacy.

Dr. W. Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual disease

Learn what an invasive breast cancer diagnosis means and explore treatment options, including surgery and targeted therapy, in this patient education guide.

The DONNA Foundation announced a matching gift challenge supporting fundraising efforts for its annual Celebrate Every Mom campaign.

Breast cancer survivor Dr. Sheri Prentiss discusses shifting oncology care from a "wait and see" approach to early lymphedema intervention and advocacy.

Dr. Reshma Jagsi discusses optimizing breast cancer care by safely de-escalating surgery and radiation using patient-centered communication

Following her breast cancer diagnosis, Guerdy Abraira utilized genomic testing to gain clarity on her treatment path.